Latest Breaking News On - Andy sklawer - Page 1 : comparemela.com

Fresh Tracks Therapeutics (FRTX) Announces Positive Topline Results from Single and Multiple Ascending Dose Parts of Phase 1 Study of Oral DYRK1A Inhibitor FRTX-02

Fresh Tracks Therapeutics (FRTX) Announces Positive Topline Results from Single and Multiple Ascending Dose Parts of Phase 1 Study of Oral DYRK1A Inhibitor FRTX-02
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Bernard khorAndy sklawerUniversity of washingtonCompany nasdaqCompany board of directorsHealth partnersCompany boardBenaroya research institute for translational medicineFresh tracks therapeutics incTracks therapeuticsChief executive officerPrincipal investigatorAssistant memberBenaroya research instituteTranslational medicineAffiliated assistant professor

Fresh Tracks Therapeutics : Company Overview Presentation

NASDAQ: FRTX Company Overview Presentation Making Fresh Tracks in Medicine® February 2023 . | February 1, 2023

United statesSouth koreaDavid mcavoyDeepak chadhaAndy sklawerExchange commissionLeadership teamCompany overviewFresh tracks therapeutics incFresh tracksFresh tracks therapeuticsSecurities litigation reform actFresh trackUnited states securitiesTracks therapeuticsAsset sale